![]() The vaccines were administered by the four Israeli Sick Funds: insurance-based, not-for-profit organizations that provide medical services to the population as part of a universal coverage system. The country, whose population numbers roughly 9.3 million people, received its first Pfizer vaccines in December 2020 ( Cohen, 2020 Sokol, 2021). In the conclusion, I discuss the potential implications of this case for other cases.Īt the beginning of 2021, Israel became a world leader in vaccination against COVID-19. ![]() Theoretically, I suggest the term “infrastructural capital” – which I define as the resources a state can provide to an external capitalist actor by virtue of its power – to explain how Israel traded with Pfizer. Drawing on insights from the sociology of the state and from science and technology studies, I argue that Israel was able to secure vaccines by using its state-power as a form of currency. But how was Israel able to purchase large quantities of then-scarce vaccines in the first place? To answer this question, I examine reports and publications by government and civil society bodies as well as news coverage about the campaign. In the months that followed, the country became a world leader in vaccination rates. In December 2020, Israel signed an agreement with Pfizer to purchase enough doses to vaccinate its entire population. This article examines the Israeli vaccination campaign against COVID-19, focusing on the state's acquisition of the vaccines from the pharmaceutical company Pfizer.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |